ARCHIVES

NCI Raises New Questions About Duke Genomics Research, Cuts Assay From Trial

This article is from The Cancer Letter archive.

Vol. 36 No. 18 | May 14, 2010

Download PDF Visit The Full Archive

Related Articles

In Brief: House Passes Bill Extending Saccharin Status To 1981; Execs No Enthusiastic Over New SES

August 3, 1979

Progress Requires More Etiologists, D’Angio Says

September 15, 1978

Trastuzumab Showed Improved Survival In Stage IV Breast Cancer with CNS Metastases

August 26, 2011

Drasga, Einhorn Make Appeal For Single-Payer Healthcare

January 31, 2014

Ibrutinib Demonstrates Responses In Large B-Cell Lymphomas

April 27, 2012

In Brief: Chamberlain, Kupchella Lead Educators; Mattel Donates $25 Million To UCLA Children’s

November 20, 1998